Business Description
Invent Medic Sweden AB
ISIN : SE0007603402
Total Employee Number:
7Compare
Compare
Traded in other countries / regions
IMS.Sweden IPO Date
2016-02-29Description
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.68 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.88 | |||||
Beneish M-Score | -2.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.5 | |||||
3-Year EBITDA Growth Rate | 52.8 | |||||
3-Year EPS without NRI Growth Rate | 52 | |||||
3-Year FCF Growth Rate | 55.1 | |||||
3-Year Book Growth Rate | -36.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.51 | |||||
9-Day RSI | 51.72 | |||||
14-Day RSI | 50.43 | |||||
3-1 Month Momentum % | -29.14 | |||||
6-1 Month Momentum % | -60.03 | |||||
12-1 Month Momentum % | -14.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.09 | |||||
Quick Ratio | 1.8 | |||||
Cash Ratio | 0.41 | |||||
Days Inventory | 129.09 | |||||
Days Sales Outstanding | 89.72 | |||||
Days Payable | 209.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -58.1 | |||||
Shareholder Yield % | 14.16 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 78.08 | |||||
Operating Margin % | -58.89 | |||||
Net Margin % | -62.07 | |||||
EBITDA Margin % | -58.89 | |||||
FCF Margin % | -67.85 | |||||
OCF Margin % | -67.85 | |||||
ROE % | -72.82 | |||||
ROA % | -45.03 | |||||
ROIC % | -47.01 | |||||
3-Year ROIIC % | 416.09 | |||||
ROC (Joel Greenblatt) % | -1449.54 | |||||
ROCE % | -57.56 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.1 | |||||
PB Ratio | 2.64 | |||||
Price-to-Tangible-Book | 4.4 | |||||
EV-to-EBIT | -5.54 | |||||
EV-to-EBITDA | -5.54 | |||||
EV-to-Revenue | 3.26 | |||||
EV-to-FCF | -4.81 | |||||
Price-to-GF-Value | 0.73 | |||||
Earnings Yield (Greenblatt) % | -18.05 | |||||
FCF Yield % | -21.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Invent Medic Sweden AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 7.463 | ||
| EPS (TTM) (kr) | -0.035 | ||
| Beta | 1.2754 | ||
| 3-Year Sharpe Ratio | -0.38 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 96.61 | ||
| 14-Day RSI | 50.43 | ||
| 14-Day ATR (kr) | 0.020981 | ||
| 20-Day SMA (kr) | 0.13225 | ||
| 12-1 Month Momentum % | -14.6 | ||
| 52-Week Range (kr) | 0.0915 - 0.363101 | ||
| Shares Outstanding (Mil) | 181.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invent Medic Sweden AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invent Medic Sweden AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-22 | In 108 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 46 days | ||
| General meeting for 2026 | 2026-05-27 14:00 | 0.12 (+2.31%) | ||
| First quarter earnings results for 2026 | 2026-05-27 | 0.12 (+2.31%) | ||
| Annual report for 2025 | 2026-04-16 | 0.18 (-0.51%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-13 | 0.21 (-2.89%) | ||
| Third quarter earnings results for 2025 | 2025-10-24 | 0.29 (+97.50%) | ||
| Second quarter earnings results for 2025 | 2025-08-15 | 0.14 (+23.17%) | ||
| General meeting for 2025 | 2025-05-05 13:00 | 0.14 (+6.67%) | ||
| First quarter earnings results for 2025 | 2025-05-05 | 0.14 (+6.67%) |
Show
Entries
Invent Medic Sweden AB Frequently Asked Questions
What is Invent Medic Sweden AB(XSAT:IMS)'s stock price today?
The current price of XSAT:IMS is kr0.13. The 52 week high of XSAT:IMS is kr0.36 and 52 week low is kr0.09.
When is next earnings date of Invent Medic Sweden AB(XSAT:IMS)?
The next earnings date of Invent Medic Sweden AB(XSAT:IMS) is 2026-08-21.
Does Invent Medic Sweden AB(XSAT:IMS) pay dividends? If so, how much?
Invent Medic Sweden AB(XSAT:IMS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Invent Medic Sweden AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers